<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>follow up for PD</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Tamsulosin HCl 0.4 MG</td><td ID="instruction1">1 capsule Orally prn</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication2">Lisinopril 5 MG</td><td ID="instruction2">1 tablet Orally once a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication3">metFORMIN HCl ER (MOD) 500 MG</td><td ID="instruction3">1 tablet Orally twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Onglyza 5 MG</td><td ID="instruction4">1 tablet Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication5">Trulicity 1.5 MG/0.5ML</td><td ID="instruction5">as directed Subcutaneous</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication6">Carbidopa-Levodopa 25-100 MG</td><td ID="instruction6">1 tab Orally three times daily for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Atorvastatin Calcium 10 MG</td><td ID="instruction7">1 tablet Orally Once a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication8">Losartan Potassium 25 MG</td><td ID="instruction8">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Baby Aspirin</td><td ID="instruction9"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Trulicity 1.5 MG/0.5ML</td><td ID="instruction10">as directed Subcutaneous once a week</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Alfuzosin HCl</td><td ID="instruction11"/><td ID="medication11notes">5 MG once a day</td><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Are you a</td><td>nonsmoker? yes</td><td/></tr><tr><td>Additional Findings: Tobacco Non-User</td><td>Current non-smoker</td><td/></tr></tbody></table><span class="content_span">Section Notes:</span><table width="100%" border="1"><tbody><tr><td colspan="3">Patient married with 4 daughters, 7 grandchildren.  He works as a manager for a transit company.  No tobacco use.  Social EtOH use.</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Blood pressure systolic</th><td>120 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure diastolic</th><td>80 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Height</th><td>71 in</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Weight</th><td>224 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Height-cm</th><td>180.34 cm</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Weight-kg</th><td>101.6 kg</td><td>[REDACTED]</td></tr><tr><th ID="vital7">BMI</th><td>31.24 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Heart Rate</th><td>77 /min</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Neuroscience Consultants 36-First Choice Neurology</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED] El-[REDACTED]</td><td>REM sleep behavior disorder G47.52 ; Left foot pain M79.672 and [REDACTED] disease without dyskinesia or fluctuating manifestations G20.A1</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>REM sleep behavior disorder (ICD-10 - G47.52)</td><td/><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Left foot pain (ICD-10 - M79.672)</td><td>due to partial Achilles tear improved with PT; under care of podiatrist</td><td>follows with podiatrist</td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>[REDACTED] disease without dyskinesia or fluctuating manifestations (ICD-10 - G20.A1)</td><td/><td>Continue carbidopa levodopa at 8/12/4; may add a fourth dose at follow-up visit; should he have additional questions or concerns prior to his follow-up appointment will contact the office; interested in PD generation trial</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Carbidopa-Levodopa 25-100 MG</td><td>1 tab Orally three times daily for 30 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Left foot pain</td><td>follows with podiatrist</td></tr><tr><td ID="instructionpot2">[REDACTED] disease without dyskinesia or fluctuating manifestations</td><td>Continue carbidopa levodopa at 8/12/4; may add a fourth dose at follow-up visit; should he have additional questions or concerns prior to his follow-up appointment will contact the office; interested in PD generation trial</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Months, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED] El-[REDACTED], [REDACTED] 10:00:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 1067715 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>1067715</td><td align="right"><span class="bold">Provider: </span>[REDACTED] El-[REDACTED], DO</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>69 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED][REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED], MD </td></tr><tr><td colspan="2"><span class="bold">Patient's Default Facility: </span>Neuroscience Consultants 07O-FirstChoice Neurology</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   follow up for PD</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Neurological Visit</span>: <br/>       [REDACTED] male with PD being seen in follow-up. He continues taking carbidopa levodopa 25/100 3 times daily at 8/12/4. He was due for his next dose during todays visit. He denies any side effects to medication or feeling when he is due for his next dose. At [REDACTED] visit, he complains of difficulty with his speech and swallowing abilities which she attributes to an accumulation of saliva. He also describes feeling tightening of his jaw when sleeping. He denies maintaining himself physically active but states he goes on walks "occasionally." <br/> <br/>Since his previous visit, completed physical therapy for left ankle pain secondary to an Achilles tendon tear. He denies any pain at [REDACTED] visit and feels improved. He continues to feel "slight stiffness" of the left foot. <br/> <br/>At a prior visit, he stated he limited his gin intake and "only" drinks gin "on the weekends."  [REDACTED] he states he continues to drink gin about 4 times weekly for a total of 8 drinks weekly.  We again discussed the importance of him cutting down. <br/><br/>Of note, he is no longer using his BiPAP machine. He followed with [REDACTED] and per note, there was mild snoring and no evidence of OSA. <br/><br/>Prior workup: MRI brain wo contrast from [REDACTED]: No acute intracranial abnormality. Mild volume loss. Linear susceptibility artifact in the right parietal lobe, probably representing a developmental venous anomaly. Fluid in the mastoid air cells. Correlate clinically. DaT Scan from [REDACTED]: Abnormal. There is evidence of presynaptic dopaminergic deficit.EMG from 3/2021 was consistent with median neuropathies at the wrists, moderate right and mild left, and chronic right C6 radiculopathy. He denies any radicular pain.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">Constitutional</span>: <br/>      &gt; <span class="content_span">Negative for chills, fatigue, fever, and weight change</span>.   <br/>   <span class="Underline">Eyes</span>: <br/>      &gt; <span class="content_span">Negative for blurred vision, eye pain, and photophobia</span>.   <br/>   <span class="Underline">ENT</span>: <br/>      &gt; <span class="content_span">Negative for nasal congestion, non-healing nasal ulcer and sore throat</span>.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      &gt; <span class="content_span">Negative for chest pain, palpitations, tachycardia, orthopnea, and edema</span>.   <br/>   <span class="Underline">Respiratory</span>: <br/>      &gt; <span class="content_span">Negative for chronic cough, dyspnea and pleuritic chest pain</span>.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      &gt; <span class="content_span">Negative for abdominal pain, heartburn, constipation, diarrhea, and stool changes</span>.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      &gt; <span class="content_span">Negatve for hematuria and nocturia</span>.   <br/>   <span class="Underline">Integumentary</span>: <br/>      &gt; <span class="content_span">Negative for a typical moles, dry skin, purities, and rashes</span>.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      &gt; <span class="content_span">Negative for appetite changes, anhedonia, difficulty concentrating and sleeping disturbance</span>.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      &gt; <span class="content_span">Negative for arthralgias, back pain and myalgias</span>.   <br/>   <span class="Underline">Endocrine</span>: <br/>      &gt; <span class="content_span">Negative for hair loss and heat/cold intolerance</span>.   <br/>   <span class="Underline">Allergic/Immunologic</span>: <br/>      &gt; <span class="content_span">Negative for allergies, frequent illnesses, and urticaria</span>.   <br/>   <span class="Underline">Hematologic-Lymphatic</span>: <br/>      &gt; <span class="content_span">Negative for easy bruising, bleeding and lymphadenopathy</span>.   <br/>   <span class="Underline">Neurologic</span>: <br/>      &gt; <span class="content_span">See HPI</span>.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> hernia repair </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> the aforementioned procedure </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased [REDACTED] yrs,  diagnosed with Heart Disease. Mother: alive [REDACTED] yrs,  diagnosed with Diabetes. Siblings: alive. Sister: deceased. Daughter(s): alive. 1 brother(s) , 4 sister(s)  - healthy. 4 daughter(s)  - healthy. . <br/><span class="content_span">Mother alive at age [REDACTED] with underlying diabetes.  Father deceased at age [REDACTED] with coronary artery disease.</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Marital Status:</span> <br/>       Married: Yes, Yes. <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Are you a <span class="italics">nonsmoker? yes</span><br/>         Additional Findings: Tobacco Non-User <span class="italics">Current non-smoker</span><br/>   <span class="content_span">Patient married with 4 daughters, 7 grandchildren.  He works as a manager for a transit company.  No tobacco use.  Social EtOH use.</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAlfuzosin HCl      , Notes to Pharmacist: 5 MG once a dayTrulicity 1.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous once a week Losartan Potassium 25 MG Tablet 1 tablet Orally Once a day Baby Aspirin      metFORMIN HCl ER (MOD) 500 MG Tablet Extended Release 24 Hour 1 tablet Orally twice a day Carbidopa-Levodopa 25-100 MG Tablet 1 tab Orally three times daily Taking Alfuzosin HCl      , Notes to Pharmacist: 5 MG once a dayTaking Trulicity 1.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous once a week Taking Losartan Potassium 25 MG Tablet 1 tablet Orally Once a day Taking Baby Aspirin      Taking metFORMIN HCl ER (MOD) 500 MG Tablet Extended Release 24 Hour 1 tablet Orally twice a day Taking Carbidopa-Levodopa 25-100 MG Tablet 1 tab Orally three times daily Not-TakingAtorvastatin Calcium 10 MG Tablet 1 tablet Orally Once a day Tamsulosin HCl 0.4 MG Capsule 1 capsule Orally prn Lisinopril 5 MG Tablet 1 tablet Orally once a day Trulicity 1.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous  Onglyza 5 MG Tablet 1 tablet Orally Once a day Medication List reviewed and reconciled with the patientNot-Taking Atorvastatin Calcium 10 MG Tablet 1 tablet Orally Once a day Not-Taking Tamsulosin HCl 0.4 MG Capsule 1 capsule Orally prn Not-Taking Lisinopril 5 MG Tablet 1 tablet Orally once a day Not-Taking Trulicity 1.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous  Not-Taking Onglyza 5 MG Tablet 1 tablet Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> BP:: <span class="bold">120/80</span> mm Hg, Ht:: 71 in, Wt:: <span class="bold">224</span> lbs, Ht-cm: 180.34 cm, Wt-kg: 101.6 kg, BMI:: <span class="bold">31.24</span> Index, HR:: <span class="bold">77</span> /min.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">Neurological Examination:</span><br/>      Mental Status Examination:  The patient is awake, alert, and oriented to person, place, and time and is able to follow complex commands. Slight masked facial expression. Speech is clear and fluent. Recent and remote memory are intact. Attention span and concentration appear normal. Fund of knowledge is appropriate. <br/>      Cranial Nerves: I: not tested, II: Pupils are equally round and reactive to light. Visual fields are grossly full to confrontation, III, IV, VI: Extraocular muscles are intact. No gaze preference or nystagmus. There is no ptosis, V: Symmetrical facial sensation, VII: There is no facial asymmetry, slightly masked facial expression, VIII: Hearing is grossly intact, IX, X: Palate elevates symmetrically, XI: Shoulder shrug normal, XII: Tongue is midline. <br/>      Motor Examination:  Strength is 5/5 throughout the bilateral upper and lower extremities. Slight increase tone to the upper extremities. <br/>      Reflexes: 2+ throughout and symmetric, no [REDACTED] sign, no clonus. <br/>      Sensory Examination:  Intact throughout to light touch. <br/>      Coordination:  No dysmetria on F to N; No Rhomberg sign. No retropulsion. <br/>      Gait: <span class="content_span">Slightly stooped narrow-based free walking, good arm swing </span>.    <br/>   <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. [REDACTED] disease without dyskinesia or fluctuating manifestations - G20.A1 (Primary)   2. REM sleep behavior disorder - G47.52   3. Left foot pain - M79.672   <content><span class="bold">Notes : </span>due to partial Achilles tear improved with PT; under care of podiatrist</content>   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. [REDACTED] disease without dyskinesia or fluctuating manifestations</span> <br/>Start Carbidopa-Levodopa Tablet, 25-100 MG, 1 tab, Orally, three times daily, 30 days, 90, Refills 5.  <br/>Notes: Continue carbidopa levodopa at 8/12/4; may add a fourth dose at follow-up visit; should he have additional questions or concerns prior to his follow-up appointment will contact the office; interested in PD generation trial<br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Left foot pain</span> <br/>Notes: follows with podiatrist  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  Counseling: <br/>       Fall Risk <br/>          Screening: <span class="italics">No falls in the past year</span><br/>          Assessment: <span class="italics">Performed</span><br/>          Plan of Care: <span class="italics">Documented</span><br/>       BMI Care goal follow-up plan: <br/>          Above Normal BMI Follow-up <span class="italics">Dietary management education, guidance, and counseling</span><br/>   DISCLAIMER:  This document was generated/scribed by [REDACTED].<br/>Information recorded by the scribe has been reviewed and validated by me, [REDACTED] El-[REDACTED]  Recommended the patient to follow up with the primary care physician for BMI management.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Months</td></tr></tbody></table></li></ul><ul><li/></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] El-[REDACTED] , DO  on [REDACTED] 06:16 PM EST</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED] El-[REDACTED], DO</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 01:50 PM EST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>Neurological Visit</td><td/><td colspan="2"/><td><p>[REDACTED] male with PD being seen in follow-up. He continues taking carbidopa levodopa 25/100 3 times daily at 8/12/4. He was due for his next dose during todays visit. He denies any side effects to medication or feeling when he is due for his next dose. At [REDACTED] visit, he complains of difficulty with his speech and swallowing abilities which she attributes to an accumulation of saliva. He also describes feeling tightening of his jaw when sleeping. He denies maintaining himself physically active but states he goes on walks "occasionally." </p><p> </p><p>Since his previous visit, completed physical therapy for left ankle pain secondary to an Achilles tendon tear. He denies any pain at [REDACTED] visit and feels improved. He continues to feel "slight stiffness" of the left foot. </p><p> </p><p>At a prior visit, he stated he limited his gin intake and "only" drinks gin "on the weekends."  [REDACTED] he states he continues to drink gin about 4 times weekly for a total of 8 drinks weekly.  We again discussed the importance of him cutting down. </p><p>Of note, he is no longer using his BiPAP machine. He followed with [REDACTED] and per note, there was mild snoring and no evidence of OSA. </p><p>Prior workup: MRI brain wo contrast from [REDACTED]: No acute intracranial abnormality. Mild volume loss. Linear susceptibility artifact in the right parietal lobe, probably representing a developmental venous anomaly. Fluid in the mastoid air cells. Correlate clinically. DaT Scan from [REDACTED]: Abnormal. There is evidence of presynaptic dopaminergic deficit.EMG from 3/2021 was consistent with median neuropathies at the wrists, moderate right and mild left, and chronic right C6 radiculopathy. He denies any radicular pain.</p></td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="7">Neurological Examination</td><td>Cranial Nerves:</td><td colspan="2">I: not tested, II: Pupils are equally round and reactive to light. Visual fields are grossly full to confrontation, III, IV, VI: Extraocular muscles are intact. No gaze preference or nystagmus. There is no ptosis, V: Symmetrical facial sensation, VII: There is no facial asymmetry, slightly masked facial expression, VIII: Hearing is grossly intact, IX, X: Palate elevates symmetrically, XI: Shoulder shrug normal, XII: Tongue is midline</td><td rowspan="7"/></tr><tr><td>Coordination: </td><td colspan="2">No dysmetria on F to N; No Rhomberg sign. No retropulsion</td></tr><tr><td>Reflexes:</td><td colspan="2">2+ throughout and symmetric, no [REDACTED] sign, no clonus</td></tr><tr><td>Gait:</td><td colspan="2">Slightly stooped narrow-based free walking, good arm swing </td></tr><tr><td>Mental Status Examination: </td><td colspan="2">The patient is awake, alert, and oriented to person, place, and time and is able to follow complex commands. Slight masked facial expression. Speech is clear and fluent. Recent and remote memory are intact. Attention span and concentration appear normal. Fund of knowledge is appropriate</td></tr><tr><td>Motor Examination: </td><td colspan="2">Strength is 5/5 throughout the bilateral upper and lower extremities. Slight increase tone to the upper extremities</td></tr><tr><td>Sensory Examination: </td><td colspan="2">Intact throughout to light touch</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>